Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice

Sulforaphane (SFN) can effectively induce nuclear factor E2–related factor 2 (Nrf2), and zinc (Zn) can effectively induce metallothionein (MT), both of which have been shown to protect against diabetic cardiomyopathy (DCM). However, it is unclear whether combined treatment with SFN and Zn offers bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiqun, Wang, Shudong, Wang, Wanning, Chen, Jing, Zhang, Zhiguo, Zheng, Qi, Liu, Quan, Cai, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714218/
https://www.ncbi.nlm.nih.gov/pubmed/31270951
http://dx.doi.org/10.1111/jcmm.14520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714218/
https://www.ncbi.nlm.nih.gov/pubmed/31270951
http://dx.doi.org/10.1111/jcmm.14520

Ejemplares similares